Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for rheumatoid arthritis
IRCT2015030321315N1Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Aug 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by CinnaGen. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT2015030321315N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015030321315N1.